Episode 57

From Rodents to Reality: The Truth About Hantavirus

In this episode of Transmission Interrupted, host Jill Morgan sits down with Dr. Gaby Frank, internist and director of the Special Pathogens Center at Johns Hopkins, to provide clarity and insight on the current hantavirus outbreak. The conversation kicks off by demystifying essential public health terms like "isolation" and "quarantine," explaining their definitions and uses in the context of infectious diseases in the U.S. Jill and Dr. Frank then dive into the science behind hantavirus, specifically the unique Andes virus strain in Argentina and its rare but notable potential for human-to-human transmission, a distinction setting it apart from the many other hantavirus strains found throughout the Americas.

Listeners will gain a clearer understanding of how hantavirus is typically contracted—primarily from aerosolized rodent droppings rather than person-to-person transmission—and the actual risks associated with exposure. The episode highlights findings from a long-term study in Chile, which revealed only 3.3% of close contacts developed the disease, with greatest risk among household and romantic partners. Jill and Dr. Frank dispel some of the fear and misinformation circulating about hantavirus, stressing that while severe cases can occur, the general public’s risk remains very low. Through expert perspective and practical advice, this episode underscores the importance of strategic preparedness and ongoing research, empowering listeners with the knowledge they need to stay safe and informed.

Guest

Maria (Gaby) Frank, MD, FACP, SFHM

Professor of Medicine, PAR, Johns Hopkins University

Director, Johns Hopkins Special Pathogens Center

Dr. Frank is a hospitalist. Professor of Medicine PAR, and the Director of Johns Hopkins’ Special Pathogens Center Johns Hopkins Hospital in Baltimore, MD, one of the 13 Regional Emerging Special Pathogen Treatment Centers (RESPTCs). The Johns Hopkins Hospital (JHH) is a premier 1000-bed non-profit academic medical center within the larger Johns Hopkins Health System, one of the leading health care systems in the United States. The 5-hospital health system in the Baltimore-Washington area has 2513 beds (354 intensive care unit beds) and serves approximately 7 million people. JHH provides a full range of clinical services including specialty care for both adults and pediatric patients. The Johns Hopkins Hospital was ranked number one in the nation by U.S. News & World Report for 22 years of the survey's 30-year history. Before joining Johns Hopkins, Dr. Frank was the Medical Director of the biocontainment unit at Denver Health and Hospital Authority. In her role as the medical director of BCU, she served as the site Principal Investigator for the NIH-sponsored ACTT trial and is actively involved in the National Emerging Special Pathogen Training and Education Center (NETEC) and Special Pathogens Research Network (SPRN). Dr. Frank received her medical diploma from the University of Buenos Aires in Buenos Aires, Argentina, and completed a residency in Internal Medicine and another in Emergency Medicine in Argentina. She immigrated to the U.S. in 2004, where she completed another Internal Medicine Residency at the University of Colorado, joining as faculty after graduation. Her areas of interest include emergent special pathogens, and disaster preparedness and response.

Host

Jill Morgan, RN

Emory Healthcare, Atlanta, GA

Jill Morgan is a registered nurse and a subject matter expert in personal protective equipment (PPE) for NETEC. For 35 years, Jill has been an emergency department and critical care nurse, and now splits her time between education for NETEC and clinical research, most of it centering around infection prevention and personal protective equipment. She is a member of the Association for Professionals in Infection Control and Epidemiology (APIC), ASTM International, and the Association for the Advancement of Medical Instrumentation (AAMI).

Resources

About NETEC

A Partnership for Preparedness

The National Emerging Special Pathogens Training and Education Center’s mission is to set the gold standard for special pathogen preparedness and response across health systems in the U.S. with the goals of driving best practices, closing knowledge gaps, and developing innovative resources.

Our vision is a sustainable infrastructure and culture of readiness for managing suspected and confirmed special pathogen incidents across the United States public health and health care delivery systems.

For more information visit NETEC on the web at www.netec.org.

NETEC Consultation Services

Assess and Advance Your Readiness for Special Pathogens with Free, Expert Consulting.

NETEC offers free virtual and onsite readiness consulting to help health care facilities and EMS agencies prepare for special pathogen events. Our targeted support services are delivered by experts selected and assigned to each inquiry based on the unique needs of your organization. Have a question? Ask a NETEC expert.

For more information visit: netec.org/consulting-services.

Transcript
Jill Morgan:

Hello, and welcome to Transmission Interrupted.

Jill Morgan:

My name is Jill Morgan.

Jill Morgan:

I'm a nurse here at Emory University Hospital in Atlanta, Georgia.

Jill Morgan:

For those of you not yet familiar with NETEC, our mission is to set the gold

Jill Morgan:

standard for special pathogen preparedness and response across health systems in

Jill Morgan:

the U.S., with the goals of driving best practices and closing knowledge gaps

Jill Morgan:

and developing innovative resources.

Jill Morgan:

NETEC works alongside and in cooperation with the CDC, and is

Jill Morgan:

funded by ASPR, the Administration for Strategic Preparedness and Response.

Jill Morgan:

And speaking of strategic preparedness and response, we are going to talk today with

Jill Morgan:

Dr. Gaby Frank, who's an internist and a professor of medicine at Johns Hopkins.

Jill Morgan:

She is the director of the Special Pathogens Center at Johns Hopkins, and has

Jill Morgan:

joined us before for conversations about hanta I don't think we could have a more

Jill Morgan:

timely conversation than this, to sort of set the record straight a little bit.

Jill Morgan:

So welcome, Gaby, So happy to have you with us today.

Gaby Frank:

Thank you for having me back.

Gaby Frank:

It was, it's always great to spend some time with you, Jill.

Jill Morgan:

Yeah.

Jill Morgan:

So let's start out.

Jill Morgan:

I just wanna maybe set the stage a little bit because I know there

Jill Morgan:

are a lot of questions that people have about all these things, right?

Jill Morgan:

It's the question of what do some of these things mean, these terms?

Jill Morgan:

Where do we get them from?

Jill Morgan:

What is isolation, and what is quarantine?

Jill Morgan:

So I want to start with just, like, setting the stage there and understanding

Jill Morgan:

that these are the terms as we define them here in the United States, and that

Jill Morgan:

because this is a public health, these are public health terms, they may be

Jill Morgan:

defined differently in other countries.

Jill Morgan:

Other people may use different terms or maybe use these a little bit

Jill Morgan:

more interchangeably than we do.

Jill Morgan:

But here in the United States, and again, this is from our Health and Human

Jill Morgan:

Services Administration, isolation is really what we think of, like, if you

Jill Morgan:

had a person, maybe they've got, I don't know, some infectious disease in

Jill Morgan:

the hospital and they're in isolation.

Jill Morgan:

And that's a sick person with a contagious disease, and we're isolating them to

Jill Morgan:

keep other people from getting sick.

Jill Morgan:

So we're keeping the sick person away from other people.

Jill Morgan:

When we think about quarantine, we're still separating them, and in most

Jill Morgan:

cases, when we say quarantine here in the U.S., we're talking about actually

Jill Morgan:

restricting the movement of people.

Jill Morgan:

They may not be sick though.

Jill Morgan:

These are people who were exposed to a contagious disease, and we're watching

Jill Morgan:

them to see if in fact they become sick.

Jill Morgan:

Because for some contagious diseases, and I'm not saying this is true for hanta,

Jill Morgan:

I'm not sure how much we know yet, but for some contagious diseases, they could

Jill Morgan:

spread that before they even get sick.

Jill Morgan:

So famously of course, if you have somebody with measles, you can spread

Jill Morgan:

measles even before you develop symptoms.

Jill Morgan:

So it's really important, that these kinds of measures can be put in place

Jill Morgan:

to help protect others who are just sort of innocent victims and might run

Jill Morgan:

into people or be in contact with folks.

Jill Morgan:

You certainly wouldn't want the people who are serving you food or

Jill Morgan:

working right next to your cubicle in the office or wherever you are,

Jill Morgan:

to have something highly contagious.

Jill Morgan:

You would like to think that they could be separated if that were possible.

Jill Morgan:

So let's just start there, and then let's dive into a little

Jill Morgan:

bit about this hanta outbreak.

Jill Morgan:

I guess, Gaby, to me, this is certainly not what we were thinking of when

Jill Morgan:

you and I last talked about hanta.

Jill Morgan:

Can you just give a little bit of an overview of the species of the

Jill Morgan:

hantavirus that's in question here, and a little bit of background about

Jill Morgan:

hanta and how it makes people sick?

Gaby Frank:

Absolutely.

Gaby Frank:

So for those who missed the last podcast you should go and listen to it.

Gaby Frank:

It was a lot of fun.

Gaby Frank:

And there's a lot of great information shared on that one.

Gaby Frank:

So, and probably for those who listen to us, this is gonna be repeated

Gaby Frank:

information, but there's many hantaviruses that are described in the

Gaby Frank:

world, over 28 or around 28 that are described to cause disease in humans.

Gaby Frank:

In the Americas, North, Central, and South America, we have a lot of different

Gaby Frank:

strains of hantavirus that cause what we call hanta pulmonary syndrome

Gaby Frank:

or hanta cardiopulmonary syndrome.

Gaby Frank:

And they are all throughout America, so we do have our own

Gaby Frank:

strains in the U.S., particularly in the area of the four corners.

Gaby Frank:

In Argentina, that is where the ship started, and I think that that's

Gaby Frank:

what we're talking about Andes virus.

Gaby Frank:

They also have many different hantaviruses, but this Andes virus strain

Gaby Frank:

is particular for the area of Patagonia.

Gaby Frank:

And this is the one that is known to cause human-to-human transmission.

Gaby Frank:

There's two strains of Andes viruses, the typical Andes virus and the

Gaby Frank:

one that is called Buenos Aires virus, the International Committee

Gaby Frank:

on Viral Taxonomy still considers it as a separate Andes virus.

Gaby Frank:

But there's two only that have been identified that can cause human-to-human

Gaby Frank:

transmission, but they're both in the same big group of Andes viruses.

Gaby Frank:

And again, this is the one in Argentina, but this is not the only hantavirus

Gaby Frank:

that people have in Argentina.

Gaby Frank:

So even when we think about exposures with rodents in Argentina, it's not

Gaby Frank:

the whole country that is at risk for getting people exposed to Andes virus.

Gaby Frank:

It's just certain particular areas of Argentina.

Gaby Frank:

And what is important to know about hanta, as we said before, particularly

Gaby Frank:

the viruses that cause hanta pulmonary syndrome, is that there's a lot of

Gaby Frank:

different strains throughout America, and most of them, people acquire

Gaby Frank:

it from contact with mice droppings that may be infected with the virus.

Gaby Frank:

So I think that knowing the precautions on how to prevent getting hantaviruses

Gaby Frank:

is key, no matter where you live.

Gaby Frank:

So I think that now that we're getting to the summer times when people start

Gaby Frank:

cleaning garages and stuff, it's always good to make sure that area is ventilated,

Gaby Frank:

that if we're gonna be generating some dust, that we wear masks and gloves.

Gaby Frank:

And just be careful because This is not about Andes virus, but, you

Gaby Frank:

know, we do have our own, hantas here that we should try to prevent.

Jill Morgan:

Yeah.

Jill Morgan:

And I think it's a really important point, I'm glad you brought this up, that

Jill Morgan:

there are these viruses that can make people sick if you get it straight from

Jill Morgan:

the rodent droppings, saliva, whatever, that's been contaminating the area.

Jill Morgan:

But for most of those, they don't make anybody else sick, right?

Jill Morgan:

So in other words, you get from this mouse, but unless somebody else

Jill Morgan:

was in contact with the mouse or the mouse stuff, we'll just call it

Jill Morgan:

stuff, they're not gonna get sick.

Jill Morgan:

So there's very little, very few of these hantaviruses that actually then

Jill Morgan:

have person-to-person spread, where if I get it, I can give it to you.

Jill Morgan:

So we have a bunch of hantaviruses.

Jill Morgan:

We have only a few that can make people sick person-to-person.

Jill Morgan:

But, all of those hantaviruses can make that one person very sick.

Jill Morgan:

Like you said, hanta pulmonary syndrome.

Jill Morgan:

I don't, you know, really I think breathing is just

Jill Morgan:

an underappreciated skill.

Jill Morgan:

It's really important.

Jill Morgan:

Nothing can make you feel worse than not being able to breathe.

Jill Morgan:

And so hanta pulmonary syndrome is a very serious thing, and this is why

Jill Morgan:

we take these pathogens so seriously.

Jill Morgan:

But again, we have all the hantaviruses you can get from the rodents.

Jill Morgan:

But if you're not exposed to the rodents, the actual odds of you getting these

Jill Morgan:

from another person are very, very small.

Jill Morgan:

So as a lesson, we want to say, "Look, you want to avoid getting them from

Jill Morgan:

the animal. You want to avoid getting them from the rodents." And as it turns

Jill Morgan:

out, even that's not that easy, right?

Jill Morgan:

I mean, I think that was one of the great things really that was sort of revelatory

Jill Morgan:

to me talking with our hantavirus expert from the University of New Mexico.

Jill Morgan:

Dr. Bradshute said, "You know, actually, as it turns out, there's a lot of

Jill Morgan:

hanta out there, and it's not making people sick." So I want to say, we're

Jill Morgan:

gonna try to fill in as many gaps in information as we can today, but there

Jill Morgan:

are still a lot of gaps out there.

Jill Morgan:

And I think, Gaby, when you and I were talking earlier, you were talking about

Jill Morgan:

some other gaps just from a clinical, like internist, your work, the things

Jill Morgan:

you wish you knew about this pathogen.

Jill Morgan:

Like, how prevalent is it?

Jill Morgan:

How many people might have been exposed and never have had symptoms?

Jill Morgan:

Where is the science on things like that?

Gaby Frank:

I think that that is one important thing to

Gaby Frank:

remember about science, right?

Gaby Frank:

we don't start knowing everything.

Gaby Frank:

So I think that what we know about different pathogens and science in

Gaby Frank:

general changes over time because the more we know, the more the opinions may

Gaby Frank:

change because we have more information to actually make recommendations, upon.

Gaby Frank:

So some of the things that we do know is, like, what are the chances that if

Gaby Frank:

you get exposed to the hanta, either from mice or from another person that

Gaby Frank:

has, in this case, Andes virus, what are the chances that you're gonna get sick?

Gaby Frank:

And that is something that we're still trying to understand.

Gaby Frank:

We talked in the last podcast how there were some seroprevalence studies

Gaby Frank:

in Europe for a different hantavirus, that they noticed that some people

Gaby Frank:

actually tested positive even though they never actually had symptoms.

Gaby Frank:

This is something that we're still lacking and we need more information on.

Gaby Frank:

What we do know, though, is that a group of researchers in Chile, what they did

Gaby Frank:

is they follow people who were in contact with 76 confirmed cases of, Andes virus.

Gaby Frank:

That is the hantavirus that we're talking about right now.

Gaby Frank:

And again, the 76 were not all at the same time.

Gaby Frank:

The study was done over many, many years.

Gaby Frank:

But they followed, like, over 470 contacts of those people, and only 3.3% of the

Gaby Frank:

contacts actually developed the disease.

Gaby Frank:

So do we know that it's always this rate?

Gaby Frank:

Do we know exactly what are the risk in each of these people that put

Gaby Frank:

them at higher risk for developing?

Gaby Frank:

What they did notice by following all of these contacts is that sexual

Gaby Frank:

intercourse was the highest risk for actually acquiring the disease.

Gaby Frank:

We do know that the close contacts are usually people who are in close,

Gaby Frank:

areas with them, either household members or romantic partners.

Gaby Frank:

So I think that there's still a lot more to learn about it.

Gaby Frank:

But even from this study, when they were following contacts of people that had

Gaby Frank:

confirmed Andes virus, 3.3% were the ones who actually developed the disease.

Gaby Frank:

There's still more to understand, right?

Gaby Frank:

We don't know how many of those who will get exposed to the virus through rodents

Gaby Frank:

will get the disease, as we still don't know how many of those who get exposed

Gaby Frank:

to someone that had Andes virus, that is the one that can transmit from person to

Gaby Frank:

person, will actually develop the disease.

Gaby Frank:

So we need to be careful and treat everybody as a potential, risk of

Gaby Frank:

developing the disease, just to make sure that we keep not just the exposed

Gaby Frank:

people safe, so we can identify the disease early and treat early, but

Gaby Frank:

also the rest of the community safe.

Jill Morgan:

I think it's a great point that, when we don't know enough, we'd

Jill Morgan:

like to think, and I hope this is a lesson, speaking as a healthcare worker,

Jill Morgan:

that we actually learned from COVID, which is we want to protect ourselves.

Jill Morgan:

We want to protect our coworkers.

Jill Morgan:

We want to protect the healthcare community, which we didn't

Jill Morgan:

necessarily do a great job of before.

Jill Morgan:

And so we're gonna sort of maybe even overprotect to start with, because

Jill Morgan:

we can always back down a little bit.

Jill Morgan:

I know that Dr. Frank, you've had the same experience where, gosh, you're

Jill Morgan:

taking care of a patient for a few days, and then suddenly somebody decides to

Jill Morgan:

put them in isolation, and you're like, "Oh my gosh, wait a minute. Like, I've

Jill Morgan:

already been in contact with them." And that's a terrible feeling, right?

Jill Morgan:

For anybody.

Jill Morgan:

We want to protect you before you have that contact.

Jill Morgan:

So I think you're right.

Jill Morgan:

There might be some things we don't know.

Jill Morgan:

We might be overshooting the protection, but we'd rather do that and be

Jill Morgan:

able to back off as we learn more than to say, "Oh, sorry, we didn't

Jill Morgan:

protect you and we should have."

Jill Morgan:

I think it's really important to go back to one of the things you mentioned

Jill Morgan:

about these are the kinds of things that maybe people don't think are so

Jill Morgan:

important when you're talking about, oh, I do research on, you know, mice

Jill Morgan:

and cactus, or I do research on, these things that are down in Patagonia.

Jill Morgan:

But We live in such a connected world.

Jill Morgan:

We want to go out and experience the world.

Jill Morgan:

We want people to travel.

Jill Morgan:

We want to travel ourselves.

Jill Morgan:

We want to be able to be out and about.

Jill Morgan:

And so the more we know about these pathogens, I mean, in some ways

Jill Morgan:

we find out some things that tell us, "Oh, well, you know what? It's

Jill Morgan:

not such a big risk." You know?

Jill Morgan:

Maybe we've overshot the risk about some of these things.

Jill Morgan:

But if we don't know anything about the pathogen, then it's just a big

Jill Morgan:

black box of confusion and fear and, that's not good for anybody.

Jill Morgan:

I think that I would like to ask about, you know, you mentioned like sexual

Jill Morgan:

contact, close rom-romantic partners, being in confined spaces versus maybe

Jill Morgan:

what we think of as casual contact.

Jill Morgan:

And so from your perspective, when somebody says, "Well, you don't seem to

Jill Morgan:

be able to get it from casual contact," is that like me going to the grocery store

Jill Morgan:

or me being on public transportation?

Jill Morgan:

Or where does casual contact end and close contact begin?

Gaby Frank:

When we're in the U.S., we need to consider the contacts per the

Gaby Frank:

CDC definition, and different countries will have different definitions.

Gaby Frank:

What is considered close contact, so everything that is not in the close

Gaby Frank:

contact is considered casual contact.

Gaby Frank:

Like when, when we're talking about human-to-human transmission, right?

Gaby Frank:

Not when we're talking about an environmental exposure, but when

Gaby Frank:

we're talking about human-to-human transmission, what they consider

Gaby Frank:

in argentina is 30 minutes less than one meter of distance, right?

Gaby Frank:

So that is like 30 minutes within one meter, that is actually pretty close.

Gaby Frank:

So I think that when we're talking about transportation, it depends

Gaby Frank:

on whether the transportation was a two-hour transportation and you're

Gaby Frank:

sharing the seat with the person versus you're like six rows back and

Gaby Frank:

there's enough ventilation in the area.

Gaby Frank:

So, I think that the definition may vary a little because it's hard

Gaby Frank:

to, when we make definitions, to address every possible scenario.

Gaby Frank:

So I think that we need to always be rational when we address

Gaby Frank:

each particular case and see do they meet the definition or not.

Gaby Frank:

But the big definition for low-risk contact is, this is for Argentina and

Gaby Frank:

this is for their definition, since the Argentina and Chile are the two countries

Gaby Frank:

that have an endemic area for Andes virus.

Gaby Frank:

So I'm using the definition from Argentina because I am originally from Argentina,

Gaby Frank:

so I'm gonna use those definitions.

Gaby Frank:

Basically low-risk contact is half hour, less than a meter.

Gaby Frank:

So that seems like probably crossing path with someone in the grocery

Gaby Frank:

store doesn't even meet the low contact, the low-risk definition,

Gaby Frank:

so it's not even considered a risk.

Gaby Frank:

And again, we live in the United States, so we need to, when we're addressing

Gaby Frank:

this, we'll go by the CDC definitions.

Gaby Frank:

That is how this varies and we need to analyze each case in

Gaby Frank:

particular when we encounter this.

Gaby Frank:

And the other thing that I wanted to bring up, again, talking about Argentina, is

Gaby Frank:

that in their epidemiological bulletin for this last season for hanta, although there

Gaby Frank:

were like around 100 cases of hantavirus diagnosed in Argentina in the last season,

Gaby Frank:

the last hanta season, only around 10 happened in endemic area for Andes virus.

Gaby Frank:

So although it's endemic area, you can see how people that live in area where

Gaby Frank:

the rodents are or there's hantavirus, there were only like, around 10 cases.

Gaby Frank:

So I think that we still need a little more understanding in what are the

Gaby Frank:

true risks, of actually developing the disease after exposure to an infected

Gaby Frank:

rodent or the infected rodent droppings.

Jill Morgan:

I'm hoping that if people can take one thing away from this today,

Jill Morgan:

it's that, yes, hanta is out there in the United States, in Central and South

Jill Morgan:

America, but generally speaking, in a form that requires humans to be in

Jill Morgan:

contact with aerosolized infected rodent urine droppings or saliva that we've

Jill Morgan:

stirred up, typically, as you said.

Jill Morgan:

Like, I'm cleaning up, I'm sweeping, I'm washing something out, I'm

Jill Morgan:

disturbing these things and I might inhale or somehow contact with

Jill Morgan:

this infected rodent excrement.

Jill Morgan:

Only of all those places that are potential exposures, which I think

Jill Morgan:

for most of us is not… you know, maybe you're camping, maybe you're

Jill Morgan:

cleaning out cabins, maybe that's your job, and that definitely

Jill Morgan:

means you need to use precautions.

Jill Morgan:

But of all those hantas, there's only a little bit that's actually then possible

Jill Morgan:

to transmit one person to another.

Jill Morgan:

And even then, with that small number of things that can be transmitted

Jill Morgan:

person to person, we think you need pretty close or sustained contact.

Jill Morgan:

Like you said, within arm's length and for about thirty minutes.

Jill Morgan:

Now, that could absolutely happen if you're stuck on a plane, train,

Jill Morgan:

automobile, in an office next to somebody, perhaps in a cubby.

Jill Morgan:

But you could also get the flu from them in those situations or some of the other

Jill Morgan:

pathogens that we transmit all the time

Jill Morgan:

So I think really it sounds like as serious as hantapulmonary or

Jill Morgan:

hantacardiopulmonary syndrome can be, and we're talking serious, like

Jill Morgan:

thirty percent fatality rate, right?

Jill Morgan:

For some of those things.

Jill Morgan:

So very serious diseases.

Jill Morgan:

They're still, luckily, amazingly difficult to get, and probably while

Jill Morgan:

we want to take them very seriously, we don't want this to rise to the

Jill Morgan:

level of really freaking people out.

Gaby Frank:

Absolutely.

Gaby Frank:

I think that we are at a point where we want to make sure that everybody's safe.

Gaby Frank:

We need to monitor the people that were exposed because, you

Gaby Frank:

know, they were sharing like in close space with, confirmed cases.

Gaby Frank:

At the same time, at this point, there is no risk for the general public.

Gaby Frank:

So, while we will still recommend to wear precautions because there's people having,

Gaby Frank:

as you said, flu or other things, we still, you know, want people to stay safe.

Gaby Frank:

But , the risk for acquiring an infection from Andes hantavirus is

Gaby Frank:

very, very low for our general public.

Gaby Frank:

So I think that what we have right now is a great national, international

Gaby Frank:

collaboration, what we actually learn from each other, and we try

Gaby Frank:

to share information so we can…

Gaby Frank:

If something like this happens again, we are a lot better prepared

Gaby Frank:

to actually prevent cases and treat people as fast as possible.

Gaby Frank:

So we're always trying to learn and do better for our communities.

Gaby Frank:

but low risk for general population at this point.

Jill Morgan:

I think that's a great way to wrap this up.

Jill Morgan:

So yes, we want to support research.

Jill Morgan:

We want to support the people doing the research that keeps us

Jill Morgan:

safe, and that means we have to look at some of these pathogens.

Jill Morgan:

We need to know things like how easy are they to get and,

Jill Morgan:

where do you get them from?

Jill Morgan:

And there are always gonna be some questions we don't have answers to.

Jill Morgan:

But as Dr. Frank said, the risk for this one for the general public is very low.

Jill Morgan:

We're hoping for the good health of anybody who is exposed,

Jill Morgan:

because if they get sick it can be quite a serious disease.

Jill Morgan:

But that doesn't mean that the rest of us who haven't been exposed

Jill Morgan:

have something big to worry about.

Jill Morgan:

So Gaby, it's such a pleasure to talk to you.

Jill Morgan:

I really enjoy spending time with you.

Jill Morgan:

I, I love to hear more about, your history with, treating these things and thinking

Jill Morgan:

about these things from the perspective of somebody who actually, lived in

Jill Morgan:

places where they are much more common.

Jill Morgan:

So thank you for joining us again today on, uh, Transmission Interrupted.

Gaby Frank:

Thank you very much for having me.

Gaby Frank:

Jill, always a pleasure.

Gaby Frank:

You're the most engaging host I've have worked with.

Gaby Frank:

You're amazing.

Jill Morgan:

Well, thank you.

Jill Morgan:

It's 'cause we always pick these interesting topics.

Jill Morgan:

For those of you listening at home, thank you for tuning in

Jill Morgan:

to this episode on Andes hanta.

Jill Morgan:

We hope you'll join us for future episodes on whichever pathogen might show up

Jill Morgan:

next, but also about healthcare worker safety, and personal protective equipment,

Jill Morgan:

and any kind of infectious disease.

Jill Morgan:

If you have questions for NETEC or ideas for future shows, please feel

Jill Morgan:

free to contact us at info@netec.org.

Jill Morgan:

That's info@netec.org.

Jill Morgan:

You can also find us on the web at netec.org/podcast, where of you can

Jill Morgan:

also subscribe to future episodes.

Jill Morgan:

So thank you so much, and we will see you next time on Transmission Interrupted.

About the Podcast

Show artwork for Transmission Interrupted
Transmission Interrupted
Presented in cooperation with the CDC and funded by ASPR, the Assistant Secretary for Preparedness and Response. For more information, visit NETEC on the web at www.netec.org.